A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to evaluate the safety and tolerability of fluticasone
furoate/GW642444 inhalation powder when administered once-daily for 52 weeks in Japanese
patients with COPD.